| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PROX.BR
|
6.35 | 2.1B | 5.34 | — | 3.74 | 11.7% | 5.0% | 73 | 81 | 11.32 | +58.7% | 70 | — |
|
KPN.AS
|
4.13 | 15.8B | 17.85 | 4.65 | 8.40 | 10.5% | 7.0% | 57 | 54 | 4.81 | +11.9% | 56 | 2.06 |
|
ORA
|
15.40 | 40.9B | 76.10 | 1.38 | 3.01 | 15.5% | 9.0% | 52 | 59 | 17.57 | +10.5% | 74 | 0.25 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.